Gelonghui October 11th | hunan er-kang pharmaceutical (300267.SZ) recently stated at the performance briefing that the company's first ore dressing plant investment in Nigeria has been basically completed, and the equipment debugging work is currently being accelerated to strive for early product delivery.
尔康制药(300267.SZ)：在尼日利亚投资的第一选矿厂建设工作已基本完成
hunan er-kang pharmaceutical (300267.SZ): The construction work of the first selected ore dressing plant investment in Nigeria has been basically completed.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated